arrow
D

David E. Thurston

King's College London
H指数:45
被引数:7,111
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer

通过克隆和亚型筛选设计的抗体药物偶联物可抑制表达CSPG4的三阴性乳腺癌的生长。

2026-03-070
OAAI
Synthesis, SAR and Biophysical Mechanism of Action of Cyclopropabenzindole-Pyridinobenzodiazepine (CBI-PDD) Guanine-Adenine DNA Cross-Linking Agents

环丙烷苯并吲哚-吡啶苯并二氮杂-CBI-PDD鸟嘌呤-腺嘌呤DNA交联剂的合成、构效关系及生物物理作用机制

2025-09-260
PRE
Synthesis and Evaluation of DNA Cross-linkers by Click Chemistry-Mediated Heterodimerization of Nor-Tomaymycins

通过点击化学介导的诺托-汤姆霉素异二聚化合成与评价DNA交联剂

2025-08-220
OAAI
A novel DNA sequence-selective, guanine mono-alkylating ADC payload suitable for solid tumour treatment

一种新型的DNA序列选择性鸟嘌呤单烷基化ADC载荷,适用于实体瘤治疗

2025-01-010
OA
DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies
2022-07-292
OAAI
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)
2020-06-0115
OAAI
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit nuclear factor-KB activity and synergize with bortezomib and ibrutinib in hematologic cancers
2020-05-076
OAAI
A new low potency DNA guanine monoalkylating ADC payload with enhanced in vivo tolerability
2019-12-010
PRE
IKS01, a next generation antibody drug conjugate, shows target-dependent efficacy in a platinum-resistant tumor model with low levels of folate receptor α expression
2019-12-010
PRE
Effect of C8-side chain on the cytotoxicity and NF-kB inhibitory capacity of pyrrolobenzodiazepines
2019-07-010
PRE
A new class of sequence-selective DNA cross-linking ADC payloads with increased in vivotolerability
2019-07-010
PRE
Development of a rapid and efficient methodology to quantitate thiol detection in antibody-drug conjugates (ADCs)
2019-07-010
PRE
Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs)
2019-01-2817
OAAI
Topical delivery of anthramycin II. Influence of binary and ternary solvent systems
2018-08-0116
OAAI
Development and evaluation of T-Zap: a novel antibody-drug conjugate for the treatment of Her2 positive breast cancer
2018-07-010
PRE
Development of an HPLC method for the assessment of hydrophobicity of ADC payloads
2018-07-010
PRE
Pyridinobenzodiazepines (PDDs): A new class of sequence-selective DNA mono-alkylating ADC payloads with low hydrophobicity
2018-07-013
PRE
Fragment-based approach to develop small-molecule STAT3 transcription factor inhibitors
2018-01-010
PRE
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
2017-11-20129
OAAI
Sequence-selective binding of C8-conjugated pyrrolobenzodiazepines (PBDs) to DNA
2017-11-015
OAAI